Azole resistance in Aspergillus isolates by different types of patients and correlation with environment - An Italian prospective multicentre study (ARiA study)

A. Prigitano, M.C. Esposto, A. Grancini, A. Biffi, P. Innocenti, C. Cavanna, F. Lallitto, E.M.G. Mollaschi, R. Bandettini, C. Oltolini, M. Passera, G. De Lorenzis, M. Sargolzaei, M. Crespan, M. Cogliati, A.M. Tortorano, L. Romanò

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)528-536
Number of pages9
JournalMycoses
Volume64
Issue number5
DOIs
Publication statusPublished - 2021

Keywords

  • A. thermomutatus
  • Aspergillus
  • Aspergillus fumigatus
  • azole resistance
  • cystic fibrosis
  • environmental origin
  • genotypic analysis
  • Italy
  • amphotericin B lipid complex
  • fluconazole
  • fungal DNA
  • genomic DNA
  • itraconazole
  • posaconazole
  • pyrrole derivative
  • voriconazole
  • adolescent
  • adult
  • aged
  • antifungal activity
  • antifungal resistance
  • antifungal susceptibility
  • antifungal therapy
  • Article
  • Aspergillus amstelodami
  • Aspergillus flavus
  • Aspergillus insuetus
  • Aspergillus lentulus
  • Aspergillus nidulans
  • Aspergillus niger
  • Aspergillus terreus
  • Aspergillus thermomutatus
  • Aspergillus versicolor
  • broth dilution
  • child
  • clinical article
  • controlled study
  • cyp51a gene
  • demography
  • female
  • fungal gene
  • fungus isolation
  • gene sequence
  • genotype
  • human
  • human tissue
  • male
  • microsatellite marker
  • middle aged
  • minimum inhibitory concentration
  • multicenter study
  • nonhuman
  • observational study
  • priority journal
  • prospective study
  • school child
  • young adult

Cite this